Cell and gene therapies have a potential, unlike anything we’ve ever seen before in medicine. With the power to deliver curative relief...
Read more
Articles Posted by Peter Dellva
Combination Drug Products– Regulatory Landscape Update
In 2016 we released a paper, “4 Things You Need to Know About Combination Drug Compliance.” This paper is still entirely relevant today, and we encourage you to download it,...
The Bustling Cell and Gene Therapy CMO Scene
Pharma’s new and exciting era of targeted therapeutics has the potential to be a turning point for modern medicine. The buzz has led to a flurry of investment in the cell...
The High Bar for Gene Therapy CMC
WHITE PAPER The High Bar for Gene Therapy CMC How drug developers can step up to meet regulatory expectations for gene therapy chemistry manufacturing and controls. After...
How the Industry’s Pandemic Response Opened the Door to Therapeutic Opportunities
The biopharma industry was certainly not immune to the turbulence brought about by the COVID-19 pandemic. The pandemic disrupted — and in some cases, stopped completely —...
